31 related articles for article (PubMed ID: 21681381)
1. NEAT expression is associated with tumor recurrence and unfavorable prognosis in colorectal cancer.
Li Y; Li Y; Chen W; He F; Tan Z; Zheng J; Wang W; Zhao Q; Li J
Oncotarget; 2015 Sep; 6(29):27641-50. PubMed ID: 26314847
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-17/20a functions to inhibit cell migration and can be used a prognostic marker in oral squamous cell carcinoma.
Chang CC; Yang YJ; Li YJ; Chen ST; Lin BR; Wu TS; Lin SK; Kuo MY; Tan CT
Oral Oncol; 2013 Sep; 49(9):923-931. PubMed ID: 23602254
[TBL] [Abstract][Full Text] [Related]
3. Targeting fibroblast growth factor (FGF)-inducible 14 (Fn14) for tumor therapy.
Zaitseva O; Hoffmann A; Otto C; Wajant H
Front Pharmacol; 2022; 13():935086. PubMed ID: 36339601
[TBL] [Abstract][Full Text] [Related]
4. ATMIN enhances invasion by altering PARP1 in MSS colorectal cancer.
Li YJ; Yang CN; Kuo MY; Lai WT; Wu TS; Lin BR
Am J Cancer Res; 2022; 12(8):3799-3810. PubMed ID: 36119811
[TBL] [Abstract][Full Text] [Related]
5. Road to Metastasis: The TWEAK Pathway as a Discriminant between Metastasizing and Non-Metastasizing Thick Melanomas.
Güvenç C; Antoranz A; Szumera-Ciećkiewicz A; Teterycz PP; Rutkowski PR; Rawson RV; Scolyer RA; Thompson JF; Newton-Bishop J; Stas M; Boecxstaens V; Bechter O; Vercauteren J; Garmyn M; van den Oord J; Bosisio FM
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638912
[TBL] [Abstract][Full Text] [Related]
6. ATMIN Suppresses Metastasis by Altering the WNT-Signaling Pathway via PARP1 in MSI-High Colorectal Cancer.
Li YJ; Yang CN; Kuo MY; Lai WT; Wu TS; Lin BR
Ann Surg Oncol; 2021 Dec; 28(13):8544-8554. PubMed ID: 34148137
[TBL] [Abstract][Full Text] [Related]
7. Key biomarkers within the colorectal cancer related inflammatory microenvironment.
Calu V; Ionescu A; Stanca L; Geicu OI; Iordache F; Pisoschi AM; Serban AI; Bilteanu L
Sci Rep; 2021 Apr; 11(1):7940. PubMed ID: 33846436
[TBL] [Abstract][Full Text] [Related]
8. TWEAK/Fn14 Activation Participates in Skin Inflammation.
Liu Q; Xiao S; Xia Y
Mediators Inflamm; 2017; 2017():6746870. PubMed ID: 29038621
[TBL] [Abstract][Full Text] [Related]
9. TWEAK activation of the non-canonical NF-κB signaling pathway differentially regulates melanoma and prostate cancer cell invasion.
Armstrong CL; Galisteo R; Brown SA; Winkles JA
Oncotarget; 2016 Dec; 7(49):81474-81492. PubMed ID: 27821799
[TBL] [Abstract][Full Text] [Related]
10. HMGCS2 enhances invasion and metastasis via direct interaction with PPARα to activate Src signaling in colorectal cancer and oral cancer.
Chen SW; Chou CT; Chang CC; Li YJ; Chen ST; Lin IC; Kok SH; Cheng SJ; Lee JJ; Wu TS; Kuo ML; Lin BR
Oncotarget; 2017 Apr; 8(14):22460-22476. PubMed ID: 27816970
[TBL] [Abstract][Full Text] [Related]
11. The TWEAK receptor Fn14 is a potential cell surface portal for targeted delivery of glioblastoma therapeutics.
Perez JG; Tran NL; Rosenblum MG; Schneider CS; Connolly NP; Kim AJ; Woodworth GF; Winkles JA
Oncogene; 2016 Apr; 35(17):2145-55. PubMed ID: 26300004
[TBL] [Abstract][Full Text] [Related]
12. Role of Raf-kinase inhibitor protein in colorectal cancer and its regulation by hydroxycamptothecine.
Nie F; Cao J; Tong J; Zhu M; Gao Y; Ran Z
J Biomed Sci; 2015 Jul; 22(1):56. PubMed ID: 26177829
[TBL] [Abstract][Full Text] [Related]
13. The TWEAK-Fn14 system as a potential drug target.
Wajant H
Br J Pharmacol; 2013 Oct; 170(4):748-64. PubMed ID: 23957828
[TBL] [Abstract][Full Text] [Related]
14. Functional expression of TWEAK and the receptor Fn14 in human malignant ovarian tumors: possible implication for ovarian tumor intervention.
Gu L; Dai L; Cao C; Zhu J; Ding C; Xu HB; Qiu L; Di W
PLoS One; 2013; 8(3):e57436. PubMed ID: 23469193
[TBL] [Abstract][Full Text] [Related]
15. [Expression and significance of Raf kinase inhibitory protein in lung cancer].
Yang D; Qi Z
Zhongguo Fei Ai Za Zhi; 2012 Oct; 15(10):597-601. PubMed ID: 23075684
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of TWEAK expression in colorectal cancer and effect of its inhibition on invasion.
Lin BR; Huang MT; Chen ST; Jeng YM; Li YJ; Liang JT; Lee PH; Chang KJ; Chang CC
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S385-94. PubMed ID: 21681381
[TBL] [Abstract][Full Text] [Related]
17. Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients.
Al-Mulla F; Hagan S; Behbehani AI; Bitar MS; George SS; Going JJ; García JJ; Scott L; Fyfe N; Murray GI; Kolch W
J Clin Oncol; 2006 Dec; 24(36):5672-9. PubMed ID: 17179102
[TBL] [Abstract][Full Text] [Related]
18. Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer.
Karamitopoulou E; Zlobec I; Panayiotides I; Patsouris ES; Peros G; Rallis G; Lapas C; Karakitsos P; Terracciano LM; Lugli A
Hum Pathol; 2011 Dec; 42(12):1888-96. PubMed ID: 21664646
[TBL] [Abstract][Full Text] [Related]
19. Reduced Raf-1 kinase inhibitor protein expression predicts less favorable outcomes in patients with hepatic colorectal metastasis.
Kim HS; Park SJ; Lee KY; Park YK; Kim YW
Oncol Rep; 2012 Jul; 28(1):161-71. PubMed ID: 22562283
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
